StocksMarket.in

Kilitch Drugs Standalone September 2018 Net Sales at Rs 26.72 crore, up 78.76% Q-o-Q

November 08
15:32 2018
Reported Standalone quarterly numbers for Kilitch Drugs (India) are:

Net Sales at Rs 26.72 crore in September 2018 up 78.76% from Rs. 14.95 crore in September 2017.

Quarterly Net Profit at Rs. 4.49 crore in September 2018 up 100.92% from Rs. 2.23 crore in September 2017.

EBITDA stands at Rs. 6.41 crore in September 2018 up 138.29% from Rs. 2.69 crore in September 2017.

Kilitch Drugs EPS has increased to Rs. 3.20 in September 2018 from Rs. 1.69 in September 2017.

Kilitch Drugs shares closed at 196.05 on November 06, 2018 (NSE) and has given 130.65% returns over the last 6 months and 154.61% over the last 12 months.

Related Articles

Archives